UNSPSC 51191940: Thiamine disulfide phosphate

This classification denotes a b vitamin C24H36N8O10P2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HIX040UVAZ, chemically known as formamide, n,n'-(dithiobis[1-methyl-2-(2-(phosphonooxy)ethyl]-2,1-ethenediyl))bis(n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-, but more generally known as thiamine disulfide phosphate, which bears US NIH Compound Identifier 3034217. European Medicines Agency schedules Thiamine disulfide phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22636.

Most nations, for tariff and trade purposes, schedule thiamine disulfide phosphate under HS 29362200 and SITC 54113. As of Q4 2014, THIAMINE DISULFIDE PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: CC1NC(C(CN1)CN(/C(=C(\SS/C(=C(\N(C=O)CC2C(NC(NC2)C)N)/C)/CCOP(=O)(O)O)/CCOP(=O)(O)O)/C)C=O)N.

UNSPSC 51191940 Thiamine disulfide phosphate (Commodity) encompasses chemical supply products for water treatment, facility maintenance, and pharmaceutical distribution across state and local government operations. Recent solicitations show state and local buyers procuring sodium bisulfite for water pollution control and generic pharmaceuticals through cooperative purchasing arrangements, with pricing evaluated on unit-cost or competitive-bid structures. Issuing bodies include municipal water utilities, state departments administering cooperative purchasing alliances, and subordinate participating jurisdictions. Work typically involves supplying specified chemical commodities or pharmaceutical products according to bid or RFP terms, with vendors required to maintain contractual relationships with authorized wholesalers, comply with cGMP and DSCSA requirements, and carry insurance coverage including general liability and workers' compensation.

Recent opportunities span Connecticut and Minnesota. The City of Meriden issued IFB B027-15 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026, requiring performance and payment bonds and naming the city as additional insured. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, with proposals due March 26, 2026, requiring vendors to supply through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and to maintain commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000.